First Time Loading...
M

McKesson Europe AG
XHAM:CLS1

Watchlist Manager
McKesson Europe AG
XHAM:CLS1
Watchlist
Price: 24.4 EUR Market Closed
Updated: Apr 29, 2024
Section:
 

Wall Street
Price Targets

CLS1 Price Targets Summary
McKesson Europe AG

There are no price targets for CLS1.
CLS1 Lowest Forecast
Wall Street Target
Not Available
CLS1 Average Forecast
Wall Street Target
Not Available
CLS1 Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
McKesson Europe AG Competitors:
Price Targets
000705
Zhejiang Zhenyuan Share Co Ltd
107% Upside
Q
301015
Qingdao Baheal Medical Inc
65% Upside
C
2289
Charmacy Pharmaceutical Co Ltd
23% Downside
HSIC
Henry Schein Inc
11% Upside
000705
Zhejiang Zhenyuan Share Co Ltd
107% Upside
Q
301015
Qingdao Baheal Medical Inc
65% Upside
C
2289
Charmacy Pharmaceutical Co Ltd
23% Downside
HSIC
Henry Schein Inc
11% Upside
9729
Tokai Corp (Gifu)
11% Upside
SIG
Sigma Healthcare Ltd
13% Downside
HAEK
Haemato AG
59% Upside
4164
CHC Healthcare Group
26% Upside

Revenue
Forecast

Revenue Estimate
McKesson Europe AG

Revenue forecast
is not available for
McKesson Europe AG

Operating Income
Forecast

Operating Income Estimate
McKesson Europe AG

Operating Income forecast
is not available for
McKesson Europe AG

Net Income
Forecast

Net Income Estimate
McKesson Europe AG

Net Income forecast
is not available for
McKesson Europe AG

See Also

Summary
CLS1 intrinsic value, competitors valuation, and company profile.
DCF Valuation
CLS1 stock valuation using Discount Cash Flow valuation method.
Relative Valuation
CLS1 stock valuation using valuation multiples.
Wall Street Estimates
CLS1 price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
CLS1 stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CLS1's stock price target?
Not Available

CLS1 doesn't have any price targets made by Wall Street professionals.

ALPHA SPREAD
Join more than 132,400+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.